Status:

UNKNOWN

Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.

Lead Sponsor:

European Lung Cancer Working Party

Conditions:

Non Small Cell Lung Carcinoma

Eligibility:

All Genders

18+ years

Brief Summary

The primary aim of this non interventional study is to assess the independent prognostic role on overall survival of primary tumour 18F-FDG uptake value (SUVmax) measured on 18fluorodeoxyglucose posit...

Eligibility Criteria

Inclusion

  • Pathologically demonstrated NSCLC
  • Stage I-III treated by curative treatment by surgery with or without chemotherapy (induction or adjuvant) or by chemoradiotherapy
  • Inoperable patients treated by exclusive radiotherapy
  • A whole-body (skull base to mid thighs) FDG-PET or a combined FDG-PET/CT on a dedicated machine, performed before any anticancer treatment
  • FDG-PET or combined FDG-PET/CT has to be previously standardised according to the procedure described in appendix IV
  • Written informed consent
  • Accessibility to follow-up
  • Age \> 18 years

Exclusion

  • Prior anticancer treatment (surgery, radiotherapy or chemotherapy)
  • Stage IV NSCLC
  • A history of prior malignant tumour, except non-melanoma skin cancer or in situ carcinoma of the cervix and cured malignant tumour (more than 5-year disease free interval)
  • Uncontrolled diabetes mellitus (fast glycaemia above 130 mg/dl)
  • Pregnancy and lactating woman
  • Unavailability to send a copy of the PET or PET-CT (DICOM format) to the data centre

Key Trial Info

Start Date :

July 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2022

Estimated Enrollment :

340 Patients enrolled

Trial Details

Trial ID

NCT00759382

Start Date

July 1 2008

End Date

January 1 2022

Last Update

August 23 2021

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Department of Pneumology RHMS Hôpital de la Madeleine

Ath, Belgium, 7800

2

Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet

Brussels, Belgium, 1000

3

Department of Pneumology CHU Charleroi

Charleroi, Belgium, 6000

4

Department of Pneumology Hôpital Saint-Joseph

Gilly, Belgium, 6060